ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis
Guidelines sessionChairs: J. Grigg (London, United Kingdom), C. Ardura-Garcia (Bern, Switzerland), A. Möller (Zürich, Switzerland)
Aims: To describe the objectives of managing children/adolescents with bronchiectasis; to present the ERS recommendations relating to diagnosing and undertaking the minimum investigations when evaluating a child/adolescent with chronic suppurative lung disease; to explain reasons for the various recommendations and to increase awarness of the guideline’s recommendations on antibiotic treatment of exacerbations, pathogen eradication, long-term antibiotic therapy, asthma-type therapies (inhaled corticosteroids, bronchodilators), mucoactive drugs, airway clearance, disease monitoring, factors to consider before surgical treatment and the reversibility and prevention of bronchiectasis in children/adolescents.